Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Lipids|January 1, 1993
Multigram synthesis of 1-alkylamido phospholipidsJ R Surles, S Morris-Natschke, M H Marx, et al.Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|June 1, 1984
Halogenated biphenyl transport by blood componentsH B Matthews, J R Surles, J G Carver, et al.Journal of Lipid Research|February 1, 1986
Desorption chemical ionization mass spectrometry of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholines and analoguesM J Thomas, M Samuel, R L Wykle, et al.The Journal of Clinical Investigation|August 1, 1986
Binding and metabolism of platelet-activating factor by human neutrophilsJ T O'Flaherty, J R Surles, J Redman, et al.Journal of Medicinal Chemistry|October 1, 1986
Synthesis of sulfur analogues of alkyl lysophospholipid and neoplastic cell growth inhibitory propertiesS Morris-Natschke, J R Surles, L W Daniel, et al.Journal of Medicinal Chemistry|January 1, 1985
Facile synthesis of platelet-activating factor and racemic analogues containing unsaturation in the sn-1-alkyl chainJ R Surles, R L Wykle, J T O'Flaherty, et al.Lipids|November 1, 1987
Ether lipids inhibit the effects of phorbol diester tumor promotersL W Daniel, L A Etkin, B T Morrison, et al.Biochimica Et Biophysica Acta|May 13, 1987
Human neutrophils incorporate arachidonic acid and saturated fatty acids into separate molecular species of phospholipidsC L Swendsen, F H Chilton, J T O'Flaherty, et al.Research Communications in Chemical Pathology and Pharmacology|October 1, 1982
Structural features of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) required for hypotensive and platelet serotonin responsesM L Blank, E A Cress, T C Lee, et al.Research Communications in Chemical Pathology and Pharmacology|February 1, 1983
Platelet-activating factor and analogues: comparative studies with human neutrophils and rabbit plateletsJ T O'Flaherty, W L Salzer, S Cousart, et al.Pageof 2